US 10144753
Anthracycline derivatives for treating tumor diseases
granted A61PA61P35/00
Quick answer
US patent 10144753 (Anthracycline derivatives for treating tumor diseases) held by Produkem Molekulares Design GMBH expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Produkem Molekulares Design GMBH
- Grant date
- Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P35/00